MedApp Past Earnings Performance
Past criteria checks 0/6
MedApp has been growing earnings at an average annual rate of 13.8%, while the Healthcare Services industry saw earnings growing at 2.2% annually. Revenues have been growing at an average rate of 26.6% per year.
Key information
13.8%
Earnings growth rate
19.8%
EPS growth rate
| Healthcare Services Industry Growth | 16.1% |
| Revenue growth rate | 26.6% |
| Return on equity | -4.8% |
| Net Margin | -21.7% |
| Next Earnings Update | 15 May 2024 |
Recent past performance updates
Recent updates
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge
Mar 26
Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?
Jan 29Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?
Mar 12MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 18Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years
Nov 26
Revenue & Expenses BreakdownBeta
How MedApp makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6 | -1 | 3 | 0 |
| 30 Sep 23 | 5 | -2 | 4 | 0 |
| 30 Jun 23 | 6 | 0 | 4 | 0 |
| 31 Mar 23 | 6 | 2 | 3 | 0 |
| 31 Dec 22 | 7 | 1 | 5 | 0 |
| 30 Sep 22 | 9 | 2 | 5 | 0 |
| 30 Jun 22 | 12 | 3 | 5 | 0 |
| 31 Mar 22 | 14 | 4 | 6 | 0 |
| 31 Dec 21 | 13 | 4 | 5 | 0 |
| 30 Sep 21 | 14 | 7 | 6 | 0 |
| 30 Jun 21 | 11 | 5 | 5 | 0 |
| 31 Mar 21 | 8 | 3 | 4 | 0 |
| 31 Dec 20 | 6 | 2 | 3 | 0 |
| 30 Sep 20 | 4 | 1 | 3 | 0 |
| 30 Jun 20 | 3 | 0 | 2 | 0 |
| 31 Mar 20 | 3 | 0 | 2 | 0 |
| 31 Dec 19 | 3 | 1 | 2 | 0 |
| 30 Sep 19 | 0 | 0 | -1 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 0 |
| 31 Mar 19 | 0 | -1 | 0 | 0 |
| 31 Dec 18 | 0 | -2 | 2 | 0 |
| 30 Sep 18 | 0 | -4 | 5 | 0 |
| 30 Jun 18 | 0 | -4 | 4 | 0 |
| 31 Mar 18 | 0 | -3 | 3 | 0 |
| 31 Dec 17 | 0 | -2 | 2 | 0 |
| 30 Sep 17 | 0 | -1 | 1 | 0 |
| 30 Jun 17 | 0 | -1 | 1 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
| 30 Sep 16 | 0 | -1 | 1 | 0 |
| 31 Mar 16 | 0 | -1 | 0 | 0 |
| 31 Dec 15 | 0 | -1 | 0 | 0 |
| 30 Sep 15 | 0 | -1 | 1 | 0 |
| 31 Mar 15 | 1 | 0 | 1 | 0 |
| 31 Dec 14 | 1 | -1 | 1 | 0 |
| 30 Sep 14 | 1 | -5 | 1 | 0 |
| 30 Jun 14 | 1 | -3 | 2 | 0 |
| 31 Mar 14 | 1 | -4 | 1 | 0 |
| 31 Dec 13 | 2 | -4 | 1 | 0 |
| 30 Sep 13 | 2 | 1 | 1 | 0 |
| 30 Jun 13 | 2 | 0 | 1 | 0 |
Quality Earnings: MDA is currently unprofitable.
Growing Profit Margin: MDA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDA is unprofitable, but has reduced losses over the past 5 years at a rate of 13.8% per year.
Accelerating Growth: Unable to compare MDA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.7%).
Return on Equity
High ROE: MDA has a negative Return on Equity (-4.76%), as it is currently unprofitable.